Related Experiment Video
Updated: Mar 8, 2026
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
Published on: February 10, 2023
Intervention for Cardiac Repair: A Clinical Perspective
Esther Hui Na Tan, Zhe Yuan Tay, Boon Seng Soh1
1Institute of Molecular and Cell Biology - Stem Cell, Regenerative Medicine And Ageing Singapore, Singapore; Department of Biological Sciences, National University of Singapore, Singapore.
Insights
Cardiovascular disease causes significant mortality. Novel stem cell and gene therapies show promise for cardiac tissue regeneration, aiming for clinical application.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Therapy
Background:
- Cardiovascular disease is the leading global cause of death.
- Cardiac injury leads to irreversible heart damage and functional decline.
- Current treatments lack the ability to regenerate cardiac tissue or fully replace heart function.
Purpose of the Study:
- To review emerging therapies for cardiac tissue regeneration.
- To assess the clinical feasibility of novel regenerative approaches.
- To guide research towards effective bedside applications for heart repair.
Main Methods:
- Review of current stem cell and genetic therapy research.
- Analysis of preclinical data in cardiac disease models.
- Evaluation of potential for clinical translation and bedside implementation.
Main Results:
- Stem cell and genetic therapies demonstrate potential in preclinical models.
- Several novel approaches are advancing towards human clinical trials.
- Significant progress is being made in developing regenerative strategies.
Conclusions:
- Regenerative medicine offers promising avenues for treating cardiovascular disease.
- Further research is needed to optimize therapies for clinical use.
- Translational research is crucial for bringing new heart repair strategies to patients.
Abstract:
Cardiovascular disease remains the leading cause of death worldwide. Damage to the heart resulting from cardiovascular disease leads to gradual loss of function and reduced quality of life. Cardiac injury is particularly debilitating, more so than injury to any other organ, given our current inability to either generate new and functional cardiac tissue or to mimic the actions of the heart using external devices. Advances in the field of stem cells and genetics have paved the way for the development of a variety of novel therapies. A number of these therapies have shown great promise in regenerating cardiac tissue in non-human disease models and some have progressed towards clinical trials. Given the rapid progress and emergence of novel targets for therapy, it is perhaps timely that we assess the practicality of these techniques and their potential for translation to bedside. Hence, this review aims to outline the major therapies in development and to provide insight into the feasibility of the respective techniques with the hope that research can be steered towards developing therapies with greater potential of being employed at the bedside.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
08:14Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging
Published on: March 17, 2020
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:29Cardiomyopathy V: Interprofessional Care
01:26Cardiac Catheterization IV: Nursing Management
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management